SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following reports that the company is preparing a formal bid for eBay, a move aimed at transforming the retailer into a massive e-commerce player. The community is actively debating the logistics of how GameStop, with its current cash reserves, would finance an acquisition of a company significantly larger than itself, while bulls anticipate a potential short squeeze and accelerated growth.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing a sharp rally driven by heavy short interest and speculative momentum as traders position themselves ahead of the company's upcoming earnings report. The community is actively discussing the potential for a short squeeze, citing high borrow fees and limited share availability while debating the long-term strategic value of the stock's recent partnership and acquisition activity.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending as market participants debate the impact of the end of the de minimis tariff exemption on its cross-border revenue and overall profit margins. While some traders are analyzing potential downside risks and short-term volatility, others remain focused on the company's long-term reliance on AI-driven marketplace improvements and the collectibles market to sustain growth.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community doubles down on long-term conviction, fueled by developer updates regarding a pivot toward business-oriented AI utility and a continued push for organic growth. Supporters are actively rallying behind the project's longevity and educational initiatives, viewing recent price action as a prime opportunity for accumulation before potential future developments.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2025 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is currently trending as a high-conviction buyout candidate, with investors actively discussing potential interest from major players like Netflix, Amazon, or Sony following the company's recent strategic spin-off. The community is heavily focused on the studio's strong IP library and the blockbuster box office potential of the Michael Jackson biopic as key catalysts that could drive a premium acquisition.

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

Advanced Biomed Inc

Advanced Biomed Inc. is seeing intense activity driven by its status as a nano-float stock, with traders closely monitoring its potential for volatile, momentum-based price swings. Community discourse is polarized, featuring aggressive pump-and-dump warnings alongside technical setups focused on short-squeeze potential and recent corporate developments like its AI-focused acquisition.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following the announcement of a pivotal Phase 3 registration path for CAD-1005 in Heparin-Induced Thrombocytopenia, which followed a successful end-of-Phase 2 meeting with the FDA. While some investors are optimistic about the company's clinical progress and pipeline potential, a significant portion of the community is expressing frustration over frequent spam, bot activity, and concerns regarding the company's long-term financial stability and funding requirements.

$ORDI : first token deployed on Bitcoin Ordinals, with a 21 million supply. $DOGI : first token deployed on Dogecoin Ordinals, with a 21 million supply. The First DRC-20 token in the history

dogi

The DRC-20 token DOGI is gaining traction as investors highlight its integration with Doginals and the Doggy Market ecosystem alongside anticipation for upcoming utility developments. Community discussions are heavily focused on its role as a Dogecoin-based alternative to BRC-20 assets, with sentiment split between high-conviction accumulation and caution regarding broader meme coin volatility.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is currently trending as investors focus on the commercial launch of its new motion sickness treatment, NEREUS, while actively speculating on a potential buyout by major pharmaceutical firms. The community sentiment remains highly bullish, driven by the company's expanded drug pipeline and persistent rumors of acquisition interest despite recent volatility and management's ongoing regulatory battles.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing extreme volatility and heavy retail attention as traders speculate on a potential short squeeze, despite significant skepticism regarding the stock's fundamentals and long-term sustainability. Community discourse is polarized, with many bulls looking for continued upward momentum and short-squeeze mechanics, while others caution against a possible rug pull as they monitor price action and short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next?

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next...

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q1 Earnings

Pfizer sees mixed Q1 signals as growth in key drugs offsets COVID declines. Can pipeline strength and M&A bets support long-term upside?

BioNTech (BNTX) Expected to Announce Quarterly Earnings on Tuesday

BioNTech (NASDAQ:BNTX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-biontech-se-stock...

BioNTech SE Sponsored ADR $BNTX Shares Sold by Flossbach Von Storch SE

Flossbach Von Storch SE decreased its position in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 0.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,196,048 shares of the com...

HC Wainwright Reaffirms "Buy" Rating for BioNTech (NASDAQ:BNTX)

HC Wainwright reaffirmed a "buy" rating and issued a $130.00 price target on shares of BioNTech in a research note on Monday...

Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?

BMY heads into Q1 earnings with strong growth portfolio momentum, but legacy drug declines and generic pressure may weigh on overall revenue performance.

BioNTech (NASDAQ:BNTX) COO Sells $5,528,000.00 in Stock

BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) COO Sierk Poetting sold 50,000 shares of the business's stock in a transaction on Wednesday, April 22nd. The shares were sold at an average...

Sierk Poetting Sells 50,000 Shares of BioNTech (NASDAQ:BNTX) Stock

BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) COO Sierk Poetting sold 50,000 shares of the company's stock in a transaction dated Wednesday, April 22nd. The stock was sold at an average...

BioNTech (BNTX) Surges 6.1%: Is This an Indication of Further Gains?

BioNTech (BNTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Pfizer's Non-Oncology Portfolio in Focus Ahead of Q1 Earnings

PFE's non-oncology portfolio is in focus ahead of Q1, with Eliquis and Prevnar gains expected to be offset by declines in Comirnaty, Paxlovid and some specialty drugs

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$2.57	--	--	N/A
Q4 '25	-$0.19	-$1.47	-669.62%	MISSED
Q3 '25	-$1.11	-$0.14	87.41%	BEAT
Q2 '25	-$2.64	-$1.85	30.22%	BEAT
Q1 '25	-$2.57	-$2.00	21.98%	BEAT

BNTX
BioNTech SE - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest BNTX News

BNTXBioNTech SE - ADR